Moderna Stock Plunges 25% After Possible Cancer Vaccine Data Leak
2 sources·Updated October 22, 2026
Covered by 2 sources
- Financial Times·6h agoModerna shares sink after leaked cancer data missed expectations
Melanoma vaccine treatment cut risk of recurrence or death by 58% but failed to exceed Wall Street’s lofty expectations
Read at Financial Times → - Forbes Business·9h agoModerna Stock Plunges 25% After Possible Cancer Vaccine Data Leak
The drop is a sharp reversal of a massive 2026 stock rally fueled by optimism over its personalized cancer vaccine.
Read at Forbes Business →
